Form4insider filings, from the source

SEC Form 4 · accession 0001127602-15-011298

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Mar 11, 2015
Accepted (ET)
Mar 13, 2015 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMar 11, 2015M2,211$63.22A2,451D
Common StockF2Mar 11, 2015S400$160.2738D2,051D
Common StockF3Mar 11, 2015S670$161.42D1,381D
Common StockF4Mar 11, 2015S841$162.4518D540D
Common StockF5Mar 11, 2015S300$163.94D240D
Common StockF6Mar 12, 2015M4,115$34.56A4,355D
Common StockF7Mar 12, 2015S3,600$162.916D755D
Common StockF8Mar 12, 2015S515$163.5912D240D
Common StockF6Mar 12, 2015M5,547$30.75A5,787D
Common StockF9Mar 12, 2015S3,633$163.025D2,154D
Common StockF10Mar 12, 2015S1,814$163.719D340D
Common StockMar 12, 2015S100$165.13D240D
Common Stockholding———166IBy Spouse
Common Stockholding———533,094IBy Trusts

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Options$63.22Mar 11, 2015M2,211DDec 31, 2010Dec 31, 2020Common Stock2,211440,008D
Stock OptionsF6$34.56Mar 12, 2015M4,115DDec 30, 2005Dec 30, 2015Common Stock4,115148,155D
Stock OptionsF6$30.75Mar 12, 2015M5,547DDec 26, 2009Dec 31, 2017Common Stock5,547521,383D

Explanation of responses